| __timestamp | Amphastar Pharmaceuticals, Inc. | Evotec SE |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 12404000 |
| Thursday, January 1, 2015 | 37065000 | 18343000 |
| Friday, January 1, 2016 | 41199000 | 18108000 |
| Sunday, January 1, 2017 | 43415000 | 17614000 |
| Monday, January 1, 2018 | 57564000 | 35619000 |
| Tuesday, January 1, 2019 | 68853000 | 58432000 |
| Wednesday, January 1, 2020 | 67229000 | 63945000 |
| Friday, January 1, 2021 | 60932000 | 72200000 |
| Saturday, January 1, 2022 | 74771000 | 76642000 |
| Sunday, January 1, 2023 | 73741000 | 57519000 |
Cracking the code
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Amphastar Pharmaceuticals, Inc. and Evotec SE have demonstrated distinct strategies in their R&D investments. From 2014 to 2023, Amphastar's R&D expenses surged by approximately 160%, peaking in 2022. This reflects a robust focus on expanding their research capabilities. In contrast, Evotec SE, while showing a steady increase, experienced a notable dip in 2023, with R&D spending dropping by 25% from the previous year. This divergence highlights Amphastar's aggressive pursuit of innovation compared to Evotec's more fluctuating approach. As the pharmaceutical industry continues to evolve, these spending patterns may offer insights into each company's future growth and market positioning.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Amphastar Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Amphastar Pharmaceuticals, Inc.
Research and Development Investment: Ascendis Pharma A/S vs Evotec SE
R&D Insights: How Grifols, S.A. and Amphastar Pharmaceuticals, Inc. Allocate Funds
Corcept Therapeutics Incorporated or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Corcept Therapeutics Incorporated vs Evotec SE
Ionis Pharmaceuticals, Inc. vs Evotec SE: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Apellis Pharmaceuticals, Inc. and Evotec SE
Comparing Innovation Spending: Rhythm Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.
R&D Spending Showdown: ACADIA Pharmaceuticals Inc. vs Evotec SE
Protagonist Therapeutics, Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Geron Corporation vs Evotec SE